0
Article |

Field Trial of Inactivated Measles Vaccine FREE

DAVID T. KARZON, M.D.; WARREN WINKELSTEIN, M.D.; RACHEL JENSS, SC.D.; GLEN E. GRESHAM, M.D.; WILLIAM E. MOSHER, M.D.
[+] Author Affiliations

Presented at the International Conference on Measles Immunization, National Institutes of Health, Bethesda, Md., Nov. 7-9, 1961.


Am J Dis Child. 1962;103(3):425-426. doi:10.1001/archpedi.1962.02080020437054.
Text Size: A A A
Published online

Introduction and Methods  A "double-blind" field trial of the alum-precipitated, concentrated, inactivated measles vaccine developed by Warren1,2 was carried out in the kindergartens and first grades of 15 schools in Buffalo beginning March 20, 1961.3 A total of 330 children received vaccine and 319 placebo. Vaccine and placebo were administered intramuscularly in 3 doses of 0.5 cc. The first 2 injections were a week apart, and the third was given 4 weeks after the first. Within each classroom, study participants were alternated between vaccine and placebo groups.Serologic studies were carried out on a sample of 40 children. Measles surveillance was begun at the time of the first injection and continued until the closing of school on June 23.

Results  Comparison of the vaccine and placebo groups with respect to age, race, sex, socioeconomic status, and number of individuals in each household under 15 years of age revealed

REFERENCES

Warren, J., and Gallian, M. J.:  Concentrated Inactivated Measles-Virus Vaccine: I. Preparation and Antigenic Potency , Amer. J. Dis. Child. 103: this issue, page 418.
Feldman, H. A.; Novak, A., and Warren, J.: Inactivated Measles Vaccine: II. Prevention of Natural and Experimental Measles, to be published.
Winkelstein, W., Jr.; Jenss, R.; Gresham, G. E.; Karzon, D. T., and Mosher, W. E.: Inactivated Measles Vaccine: III. A Field Trial in Young School Children, to be published.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Warren, J., and Gallian, M. J.:  Concentrated Inactivated Measles-Virus Vaccine: I. Preparation and Antigenic Potency , Amer. J. Dis. Child. 103: this issue, page 418.
Feldman, H. A.; Novak, A., and Warren, J.: Inactivated Measles Vaccine: II. Prevention of Natural and Experimental Measles, to be published.
Winkelstein, W., Jr.; Jenss, R.; Gresham, G. E.; Karzon, D. T., and Mosher, W. E.: Inactivated Measles Vaccine: III. A Field Trial in Young School Children, to be published.

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.